Mary Wilcox
Nurse Practitioner · Normanna, TXNPI 1144742313
Payments from drug & device makers
Across 85 payments — averaging $33.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$445
- Lilly USA, LLC$308
- AbbVie$232
- Takeda Pharmaceuticals U.S.A., Inc.$182
- Amgen$163
- Si-bone, Inc.$131
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,82299%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $445 |
| Lilly USA, LLC | 12 | $308 |
| AbbVie | 4 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $182 |
| Amgen | 3 | $163 |
| Si-bone, Inc. | 1 | $131 |
| Eisai Inc. | 4 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Corcept Therapeutics | 1 | $112 |
| Sunovion Pharmaceuticals Inc. | 7 | $107 |
| Phathom Pharmaceuticals, Inc. | 3 | $96 |
| Inspire Medical Systems, Inc. | 1 | $80 |
| Bayer | 4 | $79 |
| Philips North America LLC | 1 | $70 |
| Exact Sciences | 3 | $64 |
| GSK | 1 | $64 |
| Lundbeck LLC | 3 | $53 |
| Viiv Healthcare Company | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Nevro Corp. | 1 | $33 |
| Medtronic | 1 | $33 |
| Hologic Sales And Service, LLC | 1 | $32 |
| EMD Serono, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $20 |
| Pfizer | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Cardiovascular Systems Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Gilead | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Corium, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$334
- iFuse Implant$131
- NURTEC ODT$125
- UBRELVY$124
- Kyprolis$113
- Korlym$112
- MOUNJARO$104
How this compares
$2,842 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 19 | $27,174 |
| JardianceEmpagliflozin | 17 | $17,900 |
| Spiriva RespimatTiotropium Bromide | 13 | $16,643 |
| OzempicSemaglutide | 16 | $14,790 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $10,407 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $4,252 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 65 | $2,073 |
| Omeprazole | 34 | $689 |
| Duloxetine Hcl | 14 | $629 |
| Atorvastatin Calcium | 88 | $566 |
| Lisinopril | 93 | $565 |
| Telmisartan | 21 | $557 |
| Levothyroxine Sodium | 60 | $518 |
| Ezetimibe | 16 | $444 |
| Amlodipine Besylate | 99 | $428 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $22 | $34,54230 claims |
| Lilly USA, LLCMounjaro | $308 | $27,17419 claims |
| Novo NordiskOzempic | $445 | $14,79016 claims |
| GSKIncruse Ellipta | $64 | $4,25211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Normanna
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.